
AI-designed drug for inflammatory bowel disease enters human clinical trials: 'A significant need'
Fox News
Inflammatory bowel disease (IBD) impacts 1.6 million people in the U.S. — and a new artificial intelligence drug from Insilico Medicine could help alleviate symptoms. The company's CEO shares details.
"You can think of Chemistry42 as a ChatGPT for new molecules." "As these drugs move from research labs to clinical settings, the public needs to understand the potential and the limitations." Melissa Rudy is the health editor and a member of the lifestyle team at Fox News Digital. Story tips can be sent to melissa.rudy@fox.com
This is Insilico’s fifth AI-designed drug to enter the pipeline.

Professors were disciplined for vulgar posts after Charlie Kirk's assassination: where are they now?
Professors reinstated after controversial Charlie Kirk assassination posts receive settlements. Austin Peay State University paid associate professor Darren Michael $500,000.












